Business Context and Reporting Period
This Form 8-K Current Report is filed by Global Medical REIT Inc. (not Chiron Real Estate Inc.) with a report date of July 7, 2016, covering events occurring on June 30, 2016, and July 1, 2016. The filing documents the completion of the Company's initial public offering (IPO) and related corporate governance changes.
Key Financial Metrics and Capital Events
- Initial Public Offering: Completed on July 1, 2016, selling 13,043,479 shares of Common Stock at $10.00 per share.
- Net Proceeds: $9.30 per share (net of underwriting discounts, advisory fees, and commissions).
- Debt Conversion: $15,030,134 of outstanding convertible debentures were converted into 1,179,019 shares of Common Stock at a conversion price of $12.748 per share.
- Equity Incentive Plan: 737,191 shares reserved for the 2016 Equity Incentive Plan, with up to an additional 136,956 shares reserved if the underwriters' overallotment option is exercised.
Note: This filing does not provide revenue, profit, cash flow, margin, or liquidity metrics for the reporting period.
Material Changes and Corporate Actions
- Management Agreement: Entered into an Amended and Restated Management Agreement with Inter-American Management, LLC on July 1, 2016, governing asset and operations management.
- Director Departure: Conn Flanigan resigned as a director effective June 30, 2016, upon the closing of the Offering. He remains Secretary and General Counsel. The resignation was not due to any disagreement with the Board.
- Unregistered Sales: Issued shares to ZH USA, LLC via debenture conversion in reliance on Section 4(a)(2) of the Securities Act.
Outlook, Risks, and Management Commentary
The filing focuses on the structural completion of the IPO and the establishment of the 2016 Equity Incentive Plan for directors, officers, and employees. The Company has entered into a new management agreement to oversee its affairs. No specific financial guidance, risk factors, or unusual items are detailed in this specific 8-K text beyond the standard disclosures regarding the IPO and equity plan.
Investor Verification Checklist
- Verify the final number of shares issued if the underwriters' overallotment option is exercised.
- Review the full text of the Amended and Restated Management Agreement (Exhibit 10.1) for fee structures and termination rights.
- Confirm the total outstanding share count post-IPO and post-conversion.
- Examine the 2016 Equity Incentive Plan (Exhibit 10.2) for specific vesting schedules and performance metrics.